Clearance Summary
Finetest Lite Blood Glucose Monitoring System received FDA 510(k) clearance under submission number K203562, sponsored by Osang Healthcare Co. , Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2021-07-13.
- Submission: K203562
- Applicant / Sponsor: Osang Healthcare Co. , Ltd.
- Clearance pathway: Special
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1345
- Decision date: 2021-07-13
Classification & Regulation
This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.